120 - Long Story Short: Using Past Infectious Diseases Lessons to Inform the Present

Speaker(s)

• 

  Karen BUSH, PhD

  Professor of Practice and Interim Director of Biotechnology
  Indiana University
  Bloomington, Indiana

  Disclosure: Allergan/Actavis : Grant/Research Support (Status: Terminated --- ); Bristol-Meyers Squibb : Other Financial or Material Support (Status: Ongoing), Retirement income (Status: Ongoing); Entasis : Advisor or Review Panel member (Status: Ongoing), Shareholder (Status: Ongoing); Fedora : Advisor or Review Panel member (Status: Ongoing), Consultant (Status: Ongoing), Shareholder (Status: Ongoing); Genentech : Consultant (Status: Ongoing); Gladius : Consultant (Status: Ongoing); Johnson & Johnson : Other Financial or Material Support (Status: Ongoing), Retirement income (Status: Ongoing), Shareholder (Status: Ongoing); Merck : Grant/Research Support (Status: Ongoing); Pfizer/AstraZeneca/Wyeth : Grant/Research Support (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Retirement income (Status: Ongoing); Shionogi : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing), Research Grant or Support (Status: Ongoing); Venatorx : Consultant (Status: Ongoing)
• ED

  Elias Durry, Dr

  Medical Officer
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Kerry Murphy, MD

  Assistant Professor of Medicine
  Albert Einstein College of Medicine/Montefiore Medical Center
  Bronx, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• describe Polio disease epidemiology and the current status of Polio Eradication efforts
• describe the influence of gender on emerging infectious diseases
• discuss development of antimicrobials to the market and implications and what we have learned for future of antimicrobial development given recent antimicrobial resistance

Presentations:

• 2:45pm – 4:00pm EDT

  “herstory” of Infectious Disease: The Story of the Gender Gap in Infectious Diseases
  Kerry Murphy, MD – Albert Einstein College of Medicine/Montefiore Medical Center
• 2:45pm – 4:00pm EDT

  Polio Eradication: The “last Mile” to Zero Cases (and Road Blocks Along the Way)
  Elias Durry, Dr – Centers for Disease Control and Prevention
• 2:45pm – 4:00pm EDT

  This Little Drug Went to the Market: What Can We Learn from Following Aztreonam to the Market into Recent Times
  Karen BUSH, PhD – Indiana University